TipRanks
Go Ultimate55% OFF

Vir Biotechnology (VIR) Balance Sheet

Vir Biotechnology Balance Sheet

Vir Biotechnology's total assets for Q2 2026 were $1.21B, an increase of 18.45% from the previous quarter. VIR total liabilities were $232.31M for the fiscal quarter, a 9.16% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 1.00B$ 1.40B$ 1.92B$ 2.80B$ 1.95B
$ 237.55M$ 248.43M$ 328.82M$ 724.13M$ 522.42M
$ 765.28M$ 1.15B$ 1.59B$ 2.08B$ 1.43B

Currency in USD

Vir Biotechnology Debt to Assets

01B2B3B0 %80 %160 %240 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets